Next in the CRISPR Portfolio: 2nd CRISPR-Based Therapy Analytical Development Summit

Thank you to our speakers, sponsors, and delegates who joined us in Boston for the 4th CRISPR 2.0 Summit! If you are interested in the 2024 event, please get in touch at

Welcome to the CRISPR Revolution

CRISPR represents the next frontier in the cell and gene therapy landscape. Spearheaded by the first gene edited therapeutic awaiting FDA approval, a mounting wave of innovative technology developments and therapeutic applications are leading to a paradigm shift in our global healthcare systems.

To this end, the 4th Annual CRISPR 2.0 Congress was the definitive guide to showcase the latest and greatest CRISPR tools being developed and applied in the therapeutic setting.

With a program co-authored by leading industry figures, over 3 days our 30+ expert speakers presented and shared expertise in the following areas:

Next-generation developments and therapeutic applications of CRISPR technologies

Innovative in vivo and ex vivo CRISPR delivery approaches

Overcoming key translational limitations facing drug developers seeking to enter the clinic

The event granted attendees with access to the most anticipated new content of the year from the likes of CRISPR Therapeutics, Editas Medicine, Caribou Biosciences, Prime Medicine, and the Doudna Lab. In addition, highly appraised networking opportunities awaited attendees who met and connected with 150+ senior CRISPR figures seeking to enhance their programs for 2024 and beyond.

As the field matures and becomes more sophisticated in its approach to drug development, make sure you join us for future instalments to keep up with this quickly evolving field.

The future of gene editing innovation starts here.

Scribe Therapeutics Logo

These companies will play a big part in fulfilling the promise of CRISPR to treat the underlying genetic cause of human diseases” - Scribe Therapeutics 

2023 Expert Speaker Faculty Included:

2023 Partners Included:

Who Attended in 2023: